Get instant alerts when news about your shares comes out. Claim your one-week free trial StreetInsider Premium here.

ACTON, Mass .– (BUSINESS WIRE) – The Insulet Corporation (NASDAQ: PODD) (Insulet or Company), with its world-leading Omnipod® brand of tubular insulin pump technology, has announced several activities in recognition of Diabetes Awareness. Month and World Diabetes Day during November.

“We are committed to improving the lives of people with diabetes and at Insulet, we strive to make Pod therapy available to anyone who needs insulin on a daily basis,” said Shacey Petrovic, president and CEO. “We are committed to influencing this global epidemic by more than 400 million people living with diabetes worldwide and currently serving about 11 to 12 million.”

Insulet will ring its almost-closed bell on the Nasdaq Stock Exchange on Monday, November 15th. Ms. Petrovic will be a member of the Insulet community, including staff, as well as clinical trial participants and health care providers, who have made a significant contribution to Ms. Petrovic’s latest innovative product, the Omnipod 5® Automated Insulin Delivery System. The Omnipod 5 will be an automated tube-free insulin delivery system with compatible telephone control in the US. The Omnipod 5 System received the designation of the U.S. Food and Drug Administration device and is currently being reviewed prior to launch.

Throughout November, Insulet will be sponsoring a number of community events, including the Virtual Children with Diabetes Friends of Life, Risely Health Together T1D, and beyond type 1 Community Table focusing on the language of diabetes. The company has also teamed up with Senita to provide a collection of fitness clothing to fund scholarships for students with diabetes with a portion of their income.

Insulet will take part in various multimedia campaigns on social media channels to increase type 1 and type 2 diabetes and to help and empower people with diabetes. Rebecca Redmond, an Omnipod client and relative of Dr. Frederick Banting’s insulin finder, will appear on several channels and stand out as Podder of the Month. Additional Omnipod brand ambassadors will share personal stories on their blogs and social media channels.

On World Diabetes Day, November 14, the Company will highlight the power and diversity of the diabetes community in a video on social media. This content supports the theme of the International Diabetes Federation (IDF) for World Diabetes Day 2020, which is Access to Diabetes Care.

Insulet staff will help raise awareness through a variety of activities throughout November, including sharing personal stories about living with the disease and dressing in blue on Fridays, a color that symbolizes diabetes.

To learn more about diabetes or to get helpful resources for living with diabetes, visit the American Diabetes Association, JDRF, and the International Diabetes Federation.

About Insulet Corporation:

Insulet Corporation (NASDAQ: PODD), headquartered in Massachusetts, is an innovative medical device company focused on simplifying the lives of people with diabetes and other conditions through its Omnipod product platform. The Omnipod Insulin Management System offers a unique alternative to traditional methods of insulin delivery. With a simple, portable design, the Pruning Boot provides up to three days of uninterrupted insulin without the need to see or handle a needle. Insulet also takes advantage of its unique Pod design by adapting its Omnipod technology platform to deliver non-insulin subcutaneous drugs to other therapeutic areas. For more information, visit: and

Forward-looking statement:

This press release may contain statements about Insulet’s expectations, expectations, intentions, beliefs or strategies for the future. These forward-looking statements are based on his current expectations and beliefs about future developments and their potential impact on Insulet. It cannot be guaranteed that future developments that will affect Insulet will be as planned. These forward-looking statements involve a number of risks, uncertainties (some of which are beyond its control) or other assumptions and other risks that may result in the actual results or performance being materially different from those expressed or implied. and the uncertainties described in the “Risk Factors” section of February 24, 2021 and the other documents occasionally conducted with the Securities and Exchange. Committee. If one or more of these risks or uncertainties are realized, or if any of its assumptions are proven wrong, the actual results may differ in material respects from those anticipated in these future statements. Insulet assumes no obligation to publicly update or revise forward-looking statements.

© 2021 Insulet Corporation. Omnipod and Omnipod 5 are registered trademarks of Insulet Corporation in the United States and other jurisdictions. All other trademarks are the property of their respective owners. The use of third-party trademarks does not imply a guarantee or any other relationship or affiliation. All rights reserved.

Investor relations:

Deborah R. Gordon

Vice President of Investor Relations

(978) 600-7717


Angela Geryak Wiczek

Chief Corporate Communications Officer

(978) 932-0611

Source: Insulet Corporation